Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate

Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate

US Patent 12246025 · Granted Mar 11, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancer with a combination of an anti-VEGF antibody and an an2025
Methods of treating cancer with a combination of an anti-VEGF antibody and an an2025
Methods of treating cancer with a combination of an anti-VEGF antibody and an an2025
Methods of treating cancer with a combination of an anti-VEGF antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an an2025
Dimeric protein with triple mutations2021
Bispecific antibodies against CD3 and CD202020
Human antibodies against tissue factor and methods of use thereof2017
Human antibodies and antibody-drug conjugates against CD742017